Items Tagged ‘Seattle Genetics’

June 1, 2012

New Class of Cancer Drugs May Be Less Toxic

By

The experimental treatment, called T-DM1, is a harbinger of a new class of cancer drugs that may be more effective and less toxic than many existing treatments. By harnessing antibodies to deliver toxic payloads to cancer cells, while largely sparing healthy cells, the drugs are a step toward the “magic bullets” against cancer first envisioned […]

View full entry

Tags: Adcetris, American Society of Clinical Oncology, Dr. Edith Perez, experimental treatment, NY Times, Paul Ehrlich, Seattle Genetics


Contact Us · Privacy Policy